Novo struggling with illegal hormone sales

Novo Nordisk says it is concerned about its reputation after efforts to stop the illegal sale of its products on the internet have proved fruitless.

Novo Nordisk, best known for its insulin, also produces a growth hormone that can be used by weightlifters.

Danish tax and crime fighting agencies say there is little they can do to stop the illegal sale of drugs on the internet because the people selling the products are often not based in Denmark.

Kaj Møller, a Novo Nordisk spokesperson, said in many cases the products for sale were knock-offs, but some of what was being sold was probably genuine and likely came from two major thefts, one in 2008 and one earlier this year.

Møller said the thefts and further sale appeared “organised”.

Politiken

SEE RELATED: Denmark a hotbed of steroid use

Interested in receiving the Morning Briefing delivered to your inbox by 8am each weekday? Sign up for the Morning Briefing or any of our other newsletters today.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.